{"Ticker": "CAH", "Company": "Cardinal Health", "Sector": "Health Care", "Updated": "2023-07-10", "Rating": [{"Date": "2023-07-10", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$100"}, {"Date": "2023-03-31", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$77"}, {"Date": "2023-02-03", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$87 to $94"}, {"Date": "2022-11-04", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Neutral", "Target_Change": "$64 to $80"}, {"Date": "2022-08-22", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$70 to $76"}, {"Date": "2022-05-26", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": ""}, {"Date": "2022-05-18", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": "$55 to $68"}, {"Date": "2022-04-12", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$74"}, {"Date": "2022-04-01", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$58"}, {"Date": "2021-08-06", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$62 to $51"}, {"Date": "2021-08-05", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Underperform", "Target_Change": "$69 to $56"}, {"Date": "2021-05-10", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$66 to $64"}, {"Date": "2021-01-08", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Underperform to Peer Perform", "Target_Change": ""}, {"Date": "2020-11-02", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$57"}, {"Date": "2020-09-25", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$61"}, {"Date": "2020-07-20", "Rating": "Upgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2020-05-15", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$48 to $64"}, {"Date": "2020-04-23", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$53"}, {"Date": "2020-03-20", "Rating": "Upgrade", "Organization": "BofA/Merrill", "Rating_Change": "Underperform to Buy", "Target_Change": "$57 to $58"}, {"Date": "2020-02-12", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Equal-Weight", "Target_Change": ""}, {"Date": "2020-02-07", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$68"}, {"Date": "2019-12-16", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2019-09-12", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2019-08-27", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2019-08-20", "Rating": "Upgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Buy", "Target_Change": "$50 to $52"}, {"Date": "2019-04-18", "Rating": "Initiated", "Organization": "Guggenheim", "Rating_Change": "Neutral", "Target_Change": ""}, {"Date": "2019-01-17", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$51"}, {"Date": "2018-11-16", "Rating": "Downgrade", "Organization": "Leerink Partners", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2018-04-24", "Rating": "Upgrade", "Organization": "Leerink Partners", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": ""}]}